Related references
Note: Only part of the references are listed.Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6
Omer Karadas et al.
NEUROLOGICAL SCIENCES (2021)
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
E. Caronna et al.
NEUROLOGIA (2021)
The COVID-19 Vaccines: Recent Development, Challenges and Prospects
Yuxin Yan et al.
VACCINES (2021)
Diagnosis and management of migraine in ten steps
Anna K. Eigenbrodt et al.
NATURE REVIEWS NEUROLOGY (2021)
Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients
Laura Ochoa-Callejero et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
Post-COVID-19 Syndrome? New daily persistent headache in the aftermath of COVID-19
Jonathan Wei Ting Wen Liu et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2020)
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
Cristina Tassorelli et al.
CEPHALALGIA (2018)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Interleukin-6 Levels in Tension Headache Patients
Abdulkadir Koçer et al.
CLINICAL JOURNAL OF PAIN (2010)
The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine
I Fidan et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
The effect of acupuncture on proinflammatory cytokine production in patients with chronic headache: A preliminary report
HJ Jeong et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2003)